1987
DOI: 10.1016/0028-2243(87)90035-9
|View full text |Cite
|
Sign up to set email alerts
|

An ovarian cancer-associated antigen that crossreacts with a pregnancy-associated protein

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

1987
1987
1998
1998

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 8 publications
(2 citation statements)
references
References 9 publications
0
2
0
Order By: Relevance
“…Regard-250 KVRLE r-* ' REFERENCES ing the strong and long term protection afforded by each pregnancy, immunological change should also be considered as a possible explanation. An ovarian cancer-associated antigen that cross-reacts with a pregnancy-associated antigen has been described (Nakai et al, 1987), but the significance of this finding is not clear. Thus, we still lack a biological explanation that can adequately account for the apparent protection against ovarian cancer of high parity and use of oral contraceptives, but no consistent relationship with other reproductive factors.…”
Section: Resultsmentioning
confidence: 99%
“…Regard-250 KVRLE r-* ' REFERENCES ing the strong and long term protection afforded by each pregnancy, immunological change should also be considered as a possible explanation. An ovarian cancer-associated antigen that cross-reacts with a pregnancy-associated antigen has been described (Nakai et al, 1987), but the significance of this finding is not clear. Thus, we still lack a biological explanation that can adequately account for the apparent protection against ovarian cancer of high parity and use of oral contraceptives, but no consistent relationship with other reproductive factors.…”
Section: Resultsmentioning
confidence: 99%
“…Retrospectively, the protein was found to be cross-reactive with the antibody against the first generation protein; 94kDa-3-protein that was originally separated from the human placenta at term, and confirmed to be a candidate of a novel pregnancy-associated and tumour-related protein (Kami et aL, 1991;Nakai et aL, 1981Nakai et aL, , 1985Nakai et aL, , 1987aNakai et aL, , 1987bNakai et aL, , 1988Nakai et aL, , 1989.…”
mentioning
confidence: 99%